1-2 of 2
Samuel Moser, MSc
Close
Sort by
Journal Articles

A New Class of T-Cell Bispecific Antibodies for the Treatment of Multiple Myeloma, Binding to B Cell Maturation Antigen and CD3 and Showing Potent, Specific Antitumor Activity in Myeloma Cells and Long Duration of Action in Cynomolgus Monkeys

Minh Diem Vu, PhD, Samuel Moser, MSc, Camille Delon, MSc, Melanie Latzko, MSc, Reto Gianotti, MSc, Remo Lüoend, BSc, Chloé Friang, MSc, Ramona Murr, MSc, Lydia Jasmin Duerner, PhD, Tina Weinzierl, PhD, Tanja Fauti, PhD, Marina Bacac, PhD, Oliver Ast, PhD, Anne Freimoser-Grundschober, PhD, Tea Rodriguez Diaz, MSc, Jörg Zielonka, PhD, Erwin van Puijenbroek, PhD, Ralf Hosse, PhD, Peter Bruenker, PhD, Ekkehard Mössner, PhD, Christian Klein, PhD, Pablo Umaña, PhD, Klaus Strein, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2998.
https://doi.org/10.1182/blood.V126.23.2998.2998
Published: 2015
Journal Articles

Novel 3 rd Generation Humanized Type II CD20 Antibody with Glycoengineered Fc and Modified Elbow Hinge for Enhanced ADCC and Superior Apoptosis Induction.

Pablo Umana, PhD, Ekkehard Moessner, Ph.D., Peter Bruenker, Ph.D., Gabriele Unsin, MSc., Ursula Puentener, MSc., Tobias Suter, Ph.D., Roger Grau, Ph.D., Carla Schmidt, Ph.D., Christian Gerdes, Ph.D., Adam Nopora, Ph.D., Monika Patre, Ph.D., Samuel Moser, MSc., Peter Sondermann, Ph.D., Luise Wheat, Ph.D., Martin J.S. Dyer, Ph.D., Sibrand Poppema, Ph.D., Sabine Bauer, Ph.D., Pamela Strein, Ph.D., Thomas Friess, Ph.D., Christian Klein, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 229.
https://doi.org/10.1182/blood.V108.11.229.229
Published: 2006